(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

RESOLVE-IT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

RESOLVE-IT

ST13

US500000088483169

Classe

42

Pedido

88483169

Registro

6236280

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

06/01/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

42

Data de depósito

21/06/2019

Data de registro

05/01/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/01/2021

Última transação

06/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

3

Tipo de titular

03

Localização do titular

WALTHAM, MA

Examinador

MICHELI,ANGELA M

Unidade examinadora

L10

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the literal element "RESOLVE-IT" and the design of a triangular shape with a notch above the letter "E", mild arcing lines bisecting the shape, on a grey rectangular background.

Titulares e representantes

Titulares

VENTUS THERAPEUTICS U.S., INC.
GENFIT société anonyme (SA)

Representantes

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Pharmaceutical researchresearch for the discovery of new drugs; scientific researchin particular in the medicalbiomedicalchemicalgeneticpharmaceutical or veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; Scientific and technological servicesscreening and selecting of pharmaceutical molecules and biomarkers in the field of biopharmaceuticals for medical research purpose; Development and establishment of biological testcell test and genetic test specifications and procedures in the field of biopharmaceuticals; Scientific and technological servicesfunctional analysis of genomics to identifycharacterizevalidate or develop biologically active nuclear receptors in the field of biopharmaceuticals; Scientific and technological servicesanalysis of biological substances in biologic fluids in the field of biopharmaceuticals; Scientific and technological servicesconducting clinical trials namelyfunctional analysis to identifycharacterizevalidate or develop biologically active pharmaceutical molecules and biomarkers in the field of biopharmaceuticals; Scientific and technological servicesconducting clinical trials namelyanalysis of biological substances in biologic fluids in the field of biopharmaceuticals; Computer programming in the field of scientific research and for the pharmaceutical industry; Scientific and technological servicesanalysis in the field of biopharmaceuticals; Technology specificationanalyzing technology requirements and developing recommendations for the computer software and systems and other technology needed to meet those requirementsin the field of biopharmaceuticals; Professional consultancynot connected with the conduct of businessin the fields of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacy

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/01/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/05/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/05/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/05/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/05/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/01/2021

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

02/12/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/12/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

13/10/2020

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

13/10/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

21/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/05/2020

PUBO

PUBLISHED FOR OPPOSITION

26/05/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/05/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/03/2020

ALIE

ASSIGNED TO LIE

24/03/2020

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

16/03/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/03/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

17/09/2019

GNRT

NON-FINAL ACTION E-MAILED

17/09/2019

CNRT

NON-FINAL ACTION WRITTEN

17/09/2019

DOCK

ASSIGNED TO EXAMINER

11/09/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/07/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/07/2019

NWAP

NEW APPLICATION ENTERED

25/06/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace RESOLVE-IT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.